Xenocs and Malvern Panalytical collaborate to advance pharmaceutical analytics

Grenoble — Xenocs, a global leader in Small Angle X-ray Scattering (SAXS) technology, and Malvern Panalytical, renowned for its expertise in materials characterization, are pleased to announce a collaboration aimed at transforming pharmaceutical analytics. This joint marketing initiative will deliver a unique, comprehensive solution to the pharmaceutical sector’s analytical challenges.

Through various initiatives, such as webinars and events, Xenocs and Malvern Panalytical will demonstrate how their combined instrumentation and expertise can drive deeper insights into pharmaceutical research and development.

The collaboration will focus on pharmaceutical applications, particularly in areas such as nucleic acid drug products, including mRNA vaccines, RNA therapeutics, and cell & gene therapies. It will also address biologics, such as peptides, where structural understanding is critical to optimizing product stability and efficacy.

Frédéric Bossan, Managing Director of Xenocs, stated “Xenocs and Malvern Panalytical provide complementary solutions to support the pharmaceutical industry in addressing its evolving challenges. We are excited about this collaboration and the benefits it will bring to our clients in this industry. Both companies are dedicated to excellence and innovation.

Martin Langley, Sector Director – Pharma and Food at Malvern Panalytical, echoed this sentiment: “This collaboration signifies a shared commitment to advancing the pharmaceutical industry and delivering enhanced value to our clients.”

This collaboration represents a significant step toward shaping the future of analytical characterization within the pharmaceutical sector. Positive outcomes are anticipated, which will enhance the industry’s capacity to meet its evolving analytical demands.

About Malvern Panalytical

Malvern Panalytical is a global leader in the analytics of material and life sciences. We unleash the power of small things to make big things happen for our customers. Our vision is to make the world cleaner, healthier, and more productive.

We partner with our customers to make their solutions possible through the power of precision measurements, our expertise, trusted data, and insights. Our people are partners in discovery. We collaborate with our customers and with each other to discover new possibilities and achieve breakthroughs.

Our culture is a healthy, high-performance culture shaped by our values: Own it, Aim High and Be True.
We’re committed to Net Zero in our own operations by 2030 and in our total value chain by 2040.
With over 2300 employees across the globe, we are part of Spectris plc, the world-leading precision measurement group.
Malvern Panalytical is a global leader in the analytics of material and life sciences, unleashing the power of small things to make significant advancements for its customers.
Malvern Panalytical. We’re big on small™

About Xenocs

Xenocs is a global leader in nanoscale characterization solutions. With over 24 years of expertise, the company offers high-performance instruments and software that combine Small and Wide Angle X-ray Scattering techniques (SAXS/WAXS). From enhancing drug development processes to optimizing nanomaterials for sustainable energy, the cutting-edge technologies offered by Xenocs empower scientists and industries to unlock new possibilities in advanced materials research.

The Xenocs team consists of passionate experts who combine scientific precision with personalized support, ensuring that every customer interaction helps advance their research goals.

Founded as a spinoff from the Institute Laue Langevin in Grenoble, France, Xenocs has its headquarters in Grenoble with subsidiaries in the USA, China, and Denmark. Supported by a broad team of agents worldwide, the company delivers its expertise directly to customers’ doorsteps.

Xenocs measures its success not just in technological advancements but in the achievements of the researchers and innovators who depend on its solutions every day.

< | >